Quantcast

Latest Angiogenesis Stories

2014-05-05 23:05:29

Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of a new clinical study supporting Nitrosigine™ inositol-stabilized arginine silicate, titled, “A Clinical Evaluation to Determine the Safety, Pharmacokinetics and Pharmacodynamics of an Inositol-Stabilized Arginine Silicate Dietary Supplement in Healthy Adult Males.” Purchase, NY (PRWEB) May 05, 2014 Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of a new clinical study...

2014-04-23 16:30:05

2014 wound healing research grant awarded to the Wound Healing Society Foundation ORLANDO, Fla., April 23, 2014 /PRNewswire-USNewswire/ -- The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly, former U.S. Olympics Marathoner, will run in the Wound Reach Foundation OUCH! Race Friday April 25(th), in Orlando, FL starting at the Gaylord Palms Hotel. Brantley will race four days after competing in the Boston Marathon. The OUCH! Race is a charity...

2014-04-21 20:21:44

INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA(TM) (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, CYRAMZA becomes the first FDA-approved treatment for patients...

2014-04-16 12:30:22

Advanced Tumor Modeling for Evaluation of Cancer Therapy Efficacy at the Cellular Level MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- SRI International has announced the availability of its PDCellX(TM) xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models provide clinically relevant information that allows researchers to evaluate the efficacy of cancer drug candidates in new models that go beyond traditional tumor xenograft...

2014-04-15 08:31:02

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today presented highlights of financial results fiscal year ended December 31, 2013, and other recent developments. http://photos.prnewswire.com/prnvar/20140415/LA04094 Focus on Gene Therapy and Regenerative Medicine Biologics The Company recently announced that the U.S.-based Cardium Therapeutics operations will be primarily focused on the clinical and commercial development...

2014-04-01 13:57:22

Wounds may heal more quickly if exposed to low-intensity vibration, report researchers at the University of Illinois at Chicago. The finding, in mice, may hold promise for the 18 million Americans who have type 2 diabetes, and especially the quarter of them who will eventually suffer from foot ulcers. Their wounds tend to heal slowly and can become chronic or worsen rapidly. Timothy Koh, UIC professor of kinesiology and nutrition in the UIC College of Applied Health Sciences, was...

2014-03-26 08:29:46

TORONTO, March 26, 2014 /CNW/ - The Gairdner Foundation is pleased to announce the winners of the 2014 Canada Gairdner Awards, recognizing some of the most significant medical discoveries from around the world. This year's winners showcase a broad range of new medical discoveries related to cardiovascular disease, cancer, immunotherapy and human parasitic diseases. Among the world's most esteemed medical research prizes, the awards distinguish Canada as a leader in science and...

2014-03-04 12:25:51

SAN DIEGO and OSAKA, Japan, March 4, 2014 /PRNewswire/ -- TRACON Pharmaceuticals (TRACON) and Santen Pharmaceutical Co., Ltd. (Santen) announced today that they have entered into an exclusive agreement for the development and global commercialization of TRACON's anti-endoglin antibodies, including TRC105, in ophthalmology. Pre-clinical and clinical data from TRACON's ongoing development of TRC105 in combination with anti-VEGF products in oncology indicate inhibiting both the...

2014-02-26 12:25:25

BOCA RATON, Fla., Feb. 26, 2014 /PRNewswire/ -- Medical studies on the potential benefits of alkaline ionized drinking water have grown more numerous in recent years. One study titled, 'Inhibitory effect of electrolyzed reduced water on tumor angiogenesis' is a remarkable discovery which cancer patients should be aware of. The study reports these findings: "ERW (Electrolyzed reduced water) counteracted the effect of A549 cell-conditioned medium and decreased total tube length."...

2014-02-21 23:02:24

Okyanos Selects Cytori To Provide Equipment And Supplies To Treat Patients With Coronary Artery Disease Using Their Own Adult Stem Cells Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, and Cytori Therapeutics have announced that they have established a ten year supply agreement for the Celution™ System family of...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related